1-1 of 1
Catherine Wiseman, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bax Degradation Activity Is a Novel Poor Prognosis Marker of Chronic Lymphocytic Leukemia.

Samir G. Agrawal, MD, PhD, Feng-Ting Liu, MB, PhD, Catherine Wiseman, PhD, Sima Shirali, PhD, Hongxiang Liu, PhD, Debra Lillington, PhD, Ming Qing Du, MB, PhD, Denise Syndercombe Court, PhD, Adrian C. Newland, MD, John G. Gribben, MD, PhD, Li Jia, MB, PhD
Journal: Blood
Blood (2007) 110 (11): 3087.
https://doi.org/10.1182/blood.V110.11.3087.3087
Published: 2007